Press Releases Year None2020201920182017 September 18, 2020 Prevail Therapeutics to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit September 10, 2020 Prevail Therapeutics Announces Appointment of William H. Carson, M.D., to Board of Directors September 2, 2020 Prevail Therapeutics to Present at Upcoming Investor Conferences August 11, 2020 Prevail Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights August 5, 2020 Prevail Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Conference August 5, 2020 Prevail Therapeutics to Webcast Conference Call of Second Quarter 2020 Financial Results July 27, 2020 Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR006 July 22, 2020 Prevail Therapeutics to Highlight Multiple Gene Therapy Programs for Neurodegenerative Diseases at the Virtual 2020 Alzheimer’s Association International Conference June 4, 2020 Prevail Therapeutics Appoints Kira Schwartz, J.D., as General Counsel May 26, 2020 Prevail Therapeutics to Present at The Jefferies Virtual Global Healthcare Conference Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 23
